Clinical Trials Directory

Trials / Completed

CompletedNCT04586816

Randomized, Double-Blind Evaluation of Maple Leaf Extract (Maplifa) for Photoaging

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
19 (actual)
Sponsor
Integrative Skin Science and Research · Industry
Sex
Female
Age
30 Years – 70 Years
Healthy volunteers
Accepted

Summary

Recent research has reported that the maple leaf extract exhibits anti-aging effects by inhibiting elastase activity, thereby preventing the breakdown of elastin and interfering with the formation of wrinkles. Red maple leaf extract contains phenolic compounds known as glucitol-core-containing gallotannins (GCGs) which help reduce the appearance of wrinkles and may decrease skin inflammation, dark spots and pigmentation. The objective of this study is to examine the effects of topical Maplifa on the cosmetic appearance of facial lines, redness and skin tone.

Conditions

Interventions

TypeNameDescription
COMBINATION_PRODUCT1% red maple leaf extract in cream base1% red maple leaf extract is combined in a cream base
COMBINATION_PRODUCT5% red maple leaf extract5% red maple leaf extract is combined in a cream base
COMBINATION_PRODUCTvehiclevehicle cream base only

Timeline

Start date
2019-09-10
Primary completion
2020-01-15
Completion
2020-01-15
First posted
2020-10-14
Last updated
2020-10-14

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04586816. Inclusion in this directory is not an endorsement.